News | December 14, 2023
Pfizer expects 2024 revenue between US$ 58.5 to US$ 61.5 billion
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
New facility is part of Aptar Pharma’s global expansion program
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
These regulatory approvals signify a significant milestone for Venus Remedies Limited
Subscribe To Our Newsletter & Stay Updated
